These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 22047609)

  • 1. The impact of comorbid cannabis use disorders on the clinical presentation of social anxiety disorder.
    Tepe E; Dalrymple K; Zimmerman M
    J Psychiatr Res; 2012 Jan; 46(1):50-6. PubMed ID: 22047609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between cannabis use disorders and social anxiety disorder in the National Epidemiological Study of Alcohol and Related Conditions (NESARC).
    Buckner JD; Heimberg RG; Schneier FR; Liu SM; Wang S; Blanco C
    Drug Alcohol Depend; 2012 Jul; 124(1-2):128-34. PubMed ID: 22266089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does comorbid Social Anxiety Disorder impact the clinical presentation of principal Major Depressive Disorder?
    Dalrymple KL; Zimmerman M
    J Affect Disord; 2007 Jun; 100(1-3):241-7. PubMed ID: 17188365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specificity of social anxiety disorder as a risk factor for alcohol and cannabis dependence.
    Buckner JD; Schmidt NB; Lang AR; Small JW; Schlauch RC; Lewinsohn PM
    J Psychiatr Res; 2008 Feb; 42(3):230-9. PubMed ID: 17320907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Which psychiatric comorbidities in cannabis dependence during adolescence? Comparison of outpatients and controls].
    Dorard G; Bungener C; Phan O; Edel Y; Corcos M; Berthoz S
    Encephale; 2018 Feb; 44(1):2-8. PubMed ID: 27637871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comorbidity in 207 cannabis users in a specific outpatient setting].
    Guillem E; Arbabzadeh-Bouchez S; Vorspan F; Bellivier F
    Encephale; 2015 Jun; 41 Suppl 1():S7-12. PubMed ID: 25123065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment-seeking for social anxiety disorder in a general outpatient psychiatry setting.
    Dalrymple KL; Zimmerman M
    Psychiatry Res; 2011 May; 187(3):375-81. PubMed ID: 21310497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peer influence and gender differences in problematic cannabis use among individuals with social anxiety.
    Buckner JD; Mallott MA; Schmidt NB; Taylor J
    J Anxiety Disord; 2006; 20(8):1087-102. PubMed ID: 16621436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association between cannabis use and anxiety disorders: Results from a population-based representative sample.
    Feingold D; Weiser M; Rehm J; Lev-Ran S
    Eur Neuropsychopharmacol; 2016 Mar; 26(3):493-505. PubMed ID: 26775742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical impact of mood disorder comorbidity on social anxiety disorder.
    Koyuncu A; Ertekin E; Binbay Z; Ozyıldırım I; Yüksel C; Tükel R
    Compr Psychiatry; 2014 Feb; 55(2):363-9. PubMed ID: 24262120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The epidemiology of social anxiety disorder in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions.
    Grant BF; Hasin DS; Blanco C; Stinson FS; Chou SP; Goldstein RB; Dawson DA; Smith S; Saha TD; Huang B
    J Clin Psychiatry; 2005 Nov; 66(11):1351-61. PubMed ID: 16420070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Social anxiety disorder and marijuana use problems: the mediating role of marijuana effect expectancies.
    Buckner JD; Schmidt NB
    Depress Anxiety; 2009; 26(9):864-70. PubMed ID: 19373871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implications of comorbid alcohol dependence among individuals with social anxiety disorder.
    Buckner JD; Timpano KR; Zvolensky MJ; Sachs-Ericsson N; Schmidt NB
    Depress Anxiety; 2008; 25(12):1028-37. PubMed ID: 18781667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age of onset of social anxiety disorder in depressed outpatients.
    Dalrymple KL; Zimmerman M
    J Anxiety Disord; 2011 Jan; 25(1):131-7. PubMed ID: 20832989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Demographic and clinical characteristics associated with comorbid cannabis use disorders (CUDs) in hospitalized patients with bipolar I disorder.
    Weinstock LM; Gaudiano BA; Wenze SJ; Epstein-Lubow G; Miller IW
    Compr Psychiatry; 2016 Feb; 65():57-62. PubMed ID: 26773991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Admixture analysis of the diagnostic subtypes of social anxiety disorder: implications for the DSM-V.
    Aderka IM; Nickerson A; Hofmann SG
    J Behav Ther Exp Psychiatry; 2012 Jun; 43(2):752-7. PubMed ID: 22104656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in clinical presentation between depressed outpatients wanting versus not wanting treatment for comorbid social anxiety disorder.
    Dalrymple KL; Zimmerman M
    J Nerv Ment Dis; 2008 Aug; 196(8):639-42. PubMed ID: 18974677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical predictors of diagnostic status in individuals with social anxiety disorder.
    Farmer AS; Gros DF; McCabe RE; Antony MM
    Compr Psychiatry; 2014 Nov; 55(8):1906-13. PubMed ID: 25236968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gender differences in social anxiety disorder: results from the national epidemiologic sample on alcohol and related conditions.
    Xu Y; Schneier F; Heimberg RG; Princisvalle K; Liebowitz MR; Wang S; Blanco C
    J Anxiety Disord; 2012 Jan; 26(1):12-9. PubMed ID: 21903358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comorbidity of social anxiety disorder and antisocial personality disorder in the National Epidemiological Survey on Alcohol and Related Conditions (NESARC).
    Galbraith T; Heimberg RG; Wang S; Schneier FR; Blanco C
    J Anxiety Disord; 2014 Jan; 28(1):57-66. PubMed ID: 24384071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.